Sanara MedTech (SMTI) Accumulated Expenses (2010 - 2026)

Sanara MedTech (SMTI) has 16 years of Accumulated Expenses data on file, last reported at $9.1 million in Q1 2026.

• Quarterly Accumulated Expenses rose 10.6% year-over-year to $9.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.1 million (up 10.6% YoY) and the FY2025 annual result came in at $11.8 million, up 16.83% from the prior year.
• Accumulated Expenses fell to $9.1 million in Q1 2026, from $11.8 million in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $11.8 million in Q4 2025 to a low of $3.1 million in Q1 2022.
• A 5-year average of $7.6 million and a median of $7.7 million in 2023 frame the typical range for Accumulated Expenses.
• Annual changes were most pronounced in 2022 — Accumulated Expenses jumped 647.29% — and 2023, when it retreated 3.89%.
• Tracing SMTI's Accumulated Expenses over 5 years: stood at $7.8 million in 2022, then slipped by 1.05% to $7.7 million in 2023, then soared by 31.37% to $10.1 million in 2024, then climbed by 16.83% to $11.8 million in 2025, then decreased by 22.91% to $9.1 million in 2026.
• The last three Accumulated Expenses figures came in at $9.1 million (Q1 2026), $11.8 million (Q4 2025), and $10.9 million (Q3 2025), per Business Quant data.